A phase I study of pazopanib with weekly paclitaxel and carboplatin in advanced solid tumors.

被引:0
|
作者
Chan, Nancy
Portal, Daniella E.
Moss, Rebecca Anne
Silk, Ann W.
Stein, Mark N.
Aisner, Joseph
Malhotra, Jyoti
Shih, Weichung
Lin, Hongxia
Kane, Michael P.
Mehnert, Janice M.
Tan, Antoinette R.
机构
[1] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[2] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
关键词
D O I
10.1200/JCO.2019.37.15_suppl.3021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3021
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors
    Tan, Antoinette R.
    Dowlati, Afshin
    Jones, Suzanne F.
    Infante, Jeffrey R.
    Nishioka, Jennifer
    Fang, Lei
    Hodge, Jeffrey P.
    Gainer, Shelby D.
    Arumugham, Thangam
    Suttle, A. Benjamin
    Dar, Mohammed M.
    Lager, Joanne J.
    Burris, Howard A., III
    ONCOLOGIST, 2010, 15 (12): : 1253 - 1261
  • [2] Phase I study of olaparib in combination with carboplatin and/or paclitaxel in patients with advanced solid tumors.
    van der Noll, Ruud
    Ang, Joo Ern
    Jager, Agnes
    Marchetti, Serena
    Mergui-Roelvink, Marja
    De Bono, Johann Sebastian
    Lolkema, Martijn
    Brunetto, Andre
    Arkenau, Hendrik-Tobias
    De Jonge, Maja J.
    van der Biessen, Diane
    Tchakov, Ilian
    Bowen, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] A phase I study of afatinib combined with carboplatin or carboplatin plus paclitaxel in patients (pts) with advanced solid tumors.
    Gao, Fangfei
    O'Brien, Mary
    Sarker, Debashis
    Bhosle, Jaishree
    Yap, Timothy Anthony
    Uttenreuther-Fischer, Martina Maria
    Pemberton, Karine
    Goeldner, Rainer-Georg
    Wiebe, Sabrina
    De Bono, Johann S.
    Spicer, James F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies
    A R Tan
    A Dowlati
    M N Stein
    S F Jones
    J R Infante
    J Bendell
    M P Kane
    K T Levinson
    A B Suttle
    H A Burris III
    British Journal of Cancer, 2014, 110 : 2647 - 2654
  • [5] Phase I study of weekly paclitaxel in combination with pazopanib and lapatinib in advanced solid malignancies
    Tan, A. R.
    Dowlati, A.
    Stein, M. N.
    Jones, S. F.
    Infante, J. R.
    Bendell, J.
    Kane, M. P.
    Levinson, K. T.
    Suttle, A. B.
    Burris, H. A., III
    BRITISH JOURNAL OF CANCER, 2014, 110 (11) : 2647 - 2654
  • [6] Phase I Study of Pazopanib in Combination with Paclitaxel and Carboplatin Given Every 21 Days in Patients with Advanced Solid Tumors
    Burris, Howard A., III
    Dowlati, Afshin
    Moss, Rebecca A.
    Infante, Jeffrey R.
    Jones, Suzanne F.
    Spigel, David R.
    Levinson, Kelly T.
    Lindquist, Diana
    Gainer, Shelby D.
    Dar, Mohammed M.
    Suttle, A. Benjamin
    Ball, Howard A.
    Tan, Antoinette R.
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (08) : 1820 - 1828
  • [7] Phase I study of ispinesib in combination with carboplatin in patients with advanced solid tumors.
    Jones, S. F.
    Plummer, E. R.
    Burris, H. A.
    Razak, A. R.
    Meluch, A. A.
    Bowen, C. J.
    Williams, D. H.
    Hodge, J. P.
    Dar, M. M.
    Calvert, A. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 85S - 85S
  • [8] Phase I study of weekly docetaxel and topotecan in the treatment of advanced solid tumors.
    Tan, BR
    Read, W
    Bergeron, K
    Fracasso, PM
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 702S - 702S
  • [9] A phase I study of lenalidomide and weekly docetaxel in patients with advanced solid tumors.
    Papadopoulos, K
    Mendelson, D
    Preston, GG
    Lopez, AM
    Ricart, AD
    Schwartz, G
    Needle, MN
    Gordon, MS
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9116S - 9116S
  • [10] Phase I study of pazopanib and ixabepilone in patients with solid tumors.
    Ganesan, Chitra
    Obulareddy, J.
    Bliss, Robin L.
    Dudek, Arkadiusz Z.
    CANCER RESEARCH, 2013, 73 (08)